{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T13:49:43Z","timestamp":1776347383235,"version":"3.51.2"},"reference-count":46,"publisher":"Impact Journals, LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"DOI":"10.18632\/aging.205759","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T13:58:35Z","timestamp":1714399115000},"source":"Crossref","is-referenced-by-count":1,"title":["EIF3B stabilizes PCNA by counteracting SYVN1-mediated ubiquitination to serve as a promotor in cholangiocarcinoma"],"prefix":"10.18632","author":[{"given":"Ranglang","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, The Third Xiangya Hospital of the Central South University, Changsha 400013, Hunan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanpin","family":"Nie","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, The Third Xiangya Hospital of the Central South University, Changsha 400013, Hunan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangliang","family":"Mi","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, The Third Xiangya Hospital of the Central South University, Changsha 400013, Hunan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenjiao","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Third Xiangya Hospital, Central South University, Changsha 400013, Hunan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixia","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Third Xiangya Hospital, Central South University, Changsha 400013, Hunan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2024,4,29]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","article-title":"Cholangiocarcinoma.","volume":"38","author":"Gores","year":"2014","journal-title":"Lancet"},{"key":"2","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","article-title":"Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise.","volume":"2","author":"Brooks","year":"2016","journal-title":"Oncologist"},{"key":"3","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/s0168-8278(02)00297-0","article-title":"Changing international trends in mortality rates for liver, biliary and pancreatic tumours.","volume":"3","author":"Thomas","year":"2002","journal-title":"J Hepatol"},{"key":"4","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1136\/gut.48.6.816","article-title":"Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998.","volume":"4","author":"Thomas","year":"2001","journal-title":"Gut"},{"key":"5","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","article-title":"Pathogenesis, diagnosis, and management of cholangiocarcinoma.","volume":"14","author":"Gores","year":"2013","journal-title":"Gastroenterology"},{"key":"6","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/00000658-200110000-00010","article-title":"Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.","volume":"23","author":"Blumgart","year":"2001","journal-title":"Ann Surg"},{"key":"7","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1245\/s10434-009-0631-1","article-title":"The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.","volume":"1","author":"Chung","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"8","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/SLA.0b013e318176c4d3","article-title":"Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.","volume":"24","author":"Abou-Alfa","year":"2008","journal-title":"Ann Surg"},{"key":"9","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/MEG.0b013e3283502241","article-title":"Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy.","volume":"2","author":"Fischer","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s00270-012-0463-4","article-title":"Yttrium-90 radioembolization for unresectable standard-chemorefractory intrahepatic cholangiocarcinoma: survival, efficacy, and safety study.","volume":"3","author":"Kim","year":"2013","journal-title":"Cardiovasc Intervent Radiol"},{"key":"11","doi-asserted-by":"publisher","first-page":"8031","DOI":"10.1074\/jbc.M115.698472","article-title":"A Hippo and Fibroblast Growth Factor Receptor Autocrine Pathway in Cholangiocarcinoma.","volume":"29","author":"Gores","year":"2016","journal-title":"J Biol Chem"},{"key":"12","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1158\/1535-7163.MCT-16-0589","article-title":"Discovery and Pharmacological Characterization of JNJ-42756493 (Erdafitinib), a Functionally Selective Small-Molecule FGFR Family Inhibitor.","volume":"1","author":"Saxty","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"13","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.molcel.2010.09.028","article-title":"Translational regulation of gene expression during conditions of cell stress.","volume":"4","author":"Willis","year":"2010","journal-title":"Mol Cell"},{"key":"14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nrm2838","article-title":"The mechanism of eukaryotic translation initiation and principles of its regulation.","volume":"1","author":"Pestova","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"15","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nature14891","article-title":"Structure of mammalian eIF3 in the context of the 43S preinitiation complex.","volume":"52","author":"Hashem","year":"2015","journal-title":"Nature"},{"key":"16","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.gene.2018.06.034","article-title":"The function and clinical significance of eIF3 in cancer.","volume":"67","author":"Zhu","year":"2018","journal-title":"Gene"},{"key":"17","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1054\/bjoc.2001.1828","article-title":"Identification of a 170-kDa protein over-expressed in lung cancers.","volume":"8","author":"Zhang","year":"2001","journal-title":"Br J Cancer"},{"key":"18","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/(sici)1097-0142(19981001)83:7<1376::aid-cncr15>3.0.co;2-1","article-title":"Expression of p150 in cervical neoplasia and its potential value in predicting survival.","volume":"8","author":"Burger","year":"1998","journal-title":"Cancer"},{"key":"19","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/ijc.20443","article-title":"p150 overexpression in gastric carcinoma: the association with p53, apoptosis and cell proliferation.","volume":"11","author":"Burger","year":"2004","journal-title":"Int J Cancer"},{"key":"20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/(sici)1097-0215(19990420)84:2<95::aid-ijc1>3.0.co;2-n","article-title":"p150 expression and its prognostic value in squamous-cell carcinoma of the esophagus.","volume":"8","author":"Burger","year":"1999","journal-title":"Int J Cancer"},{"key":"21","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s10072-011-0894-8","article-title":"Knockdown of eukaryotic translation initiation factors 3B (EIF3B) inhibits proliferation and promotes apoptosis in glioblastoma cells.","volume":"3","author":"Xu","year":"2012","journal-title":"Neurol Sci"},{"key":"22","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/cbdd.12542","article-title":"RNAi-Mediated Silencing of EIF3D Alleviates Proliferation and Migration of Glioma U251 and U87MG Cells.","volume":"8","author":"Xu","year":"2015","journal-title":"Chem Biol Drug Des"},{"key":"23","doi-asserted-by":"publisher","first-page":"e00161","DOI":"10.1042\/BSR20140078","article-title":"Lentivirus-mediated knockdown of eukaryotic translation initiation factor 3 subunit D inhibits proliferation of HCT116 colon cancer cells.","volume":"3","author":"Chai","year":"2014","journal-title":"Biosci Rep"},{"key":"24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12032-015-0625-8","article-title":"Knockdown of eIF3d inhibits cell proliferation through G2\/M phase arrest in non-small cell lung cancer.","volume":"3","author":"Lin","year":"2015","journal-title":"Med Oncol"},{"key":"25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41556-021-00835-2","article-title":"METTL16 exerts an m6A-independent function to facilitate translation and tumorigenesis.","volume":"2","author":"Prince","year":"2022","journal-title":"Nat Cell Biol"},{"key":"26","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.7150\/jca.19594","article-title":"Eukaryotic Translation Initiation Factor 3b is both a Promising Prognostic Biomarker and a Potential Therapeutic Target for Patients with Clear Cell Renal Cell Carcinoma.","volume":"8","author":"Xu","year":"2017","journal-title":"J Cancer"},{"key":"27","doi-asserted-by":"publisher","first-page":"20121","DOI":"10.1038\/srep20121","article-title":"H19 activates Wnt signaling and promotes osteoblast differentiation by functioning as a competing endogenous RNA.","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"},{"key":"28","doi-asserted-by":"publisher","first-page":"7877","DOI":"10.2147\/CMAR.S207834","article-title":"EIF3B is associated with poor outcomes in gastric cancer patients and promotes cancer progression via the PI3K\/AKT\/mTOR signaling pathway.","volume":"1","author":"Ji","year":"2019","journal-title":"Cancer Manag Res"},{"key":"29","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1158\/1078-0432.CCR-12-3084","article-title":"Translation initiation factor eIF3b expression in human cancer and its role in tumor growth and lung colonization.","volume":"1","author":"Theodorescu","year":"2013","journal-title":"Clin Cancer Res"},{"key":"30","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1038\/modpathol.3880231","article-title":"Expression of p53 and PCNA in cholangiocarcinoma and primary sclerosing cholangitis.","volume":"1","author":"Thung","year":"2000","journal-title":"Mod Pathol"},{"key":"31","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.sbi.2014.02.002","article-title":"Paradigms of protein degradation by the proteasome.","volume":"2","author":"Matouschek","year":"2014","journal-title":"Curr Opin Struct Biol"},{"key":"32","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ultsonch.2017.03.026","article-title":"Effects of ultrasound on the beef structure and water distribution during curing through protein degradation and modification.","volume":"3","author":"Zhang","year":"2017","journal-title":"Ultrason Sonochem"},{"key":"33","doi-asserted-by":"publisher","first-page":"e1004135","DOI":"10.1371\/journal.pgen.1004135","article-title":"Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma.","volume":"1","author":"Silva","year":"2014","journal-title":"PLoS Genet"},{"key":"34","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.3390\/cancers13071706","article-title":"Targeting the Fibroblast Growth Factor Receptor (FGFR) in Advanced Cholangiocarcinoma: Clinical Trial Progress and Future Considerations.","volume":"1","author":"Gong","year":"2021","journal-title":"Cancers (Basel)"},{"key":"35","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00335-020-09842-4","article-title":"Eukaryotic translation initiation factor 3 subunit b is a novel oncogenic factor in prostate cancer.","volume":"3","author":"Fan","year":"2020","journal-title":"Mamm Genome"},{"key":"36","first-page":"2228","article-title":"Autoantibody to a nuclear antigen in proliferating cells.","volume":"12","author":"Tan","year":"1978","journal-title":"J Immunol"},{"key":"37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0092-8674(88)90493-x","article-title":"Coordinated leading and lagging strand synthesis during SV40 DNA replicationrequires PCNA.","volume":"5","author":"Stillman","year":"1988","journal-title":"Cell"},{"key":"38","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1242\/jcs.00653","article-title":"Proliferating cell nuclear antigen (PCNA): a dancer with many partners.","volume":"11","author":"Hubscher","year":"2003","journal-title":"J Cell Sci"},{"key":"39","doi-asserted-by":"publisher","first-page":"22882","DOI":"10.1074\/jbc.M001850200","article-title":"A direct interaction between proliferating cell nuclear antigen (PCNA) and Cdk2 targets PCNA-interacting proteins for phosphorylation.","volume":"27","author":"H\u00fcbscher","year":"2000","journal-title":"J Biol Chem"},{"key":"40","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/369574a0","article-title":"The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA.","volume":"36","author":"Stillman","year":"1994","journal-title":"Nature"},{"key":"41","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.acthis.2016.05.002","article-title":"Ki67, PCNA, and MCM proteins: Markers of proliferation in the diagnosis of breast cancer.","volume":"11","author":"Varga","year":"2016","journal-title":"Acta Histochem"},{"key":"42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/BF02705243","article-title":"The ubiquitin-proteasome system.","volume":"3","author":"Chandu","year":"2006","journal-title":"J Biosci"},{"key":"43","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.3390\/ijms19041080","article-title":"Ubiquitin System.","volume":"1","author":"Nakamura","year":"2018","journal-title":"Int J Mol Sci"},{"key":"44","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-p","article-title":"WAF1, a potential mediator of p53 tumor suppression.","volume":"7","author":"Vogelstein","year":"1993","journal-title":"Cell"},{"key":"45","first-page":"1591","article-title":"Prognostic value of p21(WAF1) and p53 expression in breast carcinoma: an immunohistochemical study in 261 patients with long-term follow-up.","volume":"2","author":"Barbareschi","year":"1996","journal-title":"Clin Cancer Res"},{"key":"46","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3390\/genes11060593","article-title":"CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication.","volume":"1","author":"Gottifredi","year":"2020","journal-title":"Genes (Basel)"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205759","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T13:58:41Z","timestamp":1714399121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,29]]},"references-count":46,"alternative-id":["205759"],"URL":"https:\/\/doi.org\/10.18632\/aging.205759","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,29]]}}}